Category

Programme

Preclinical 

IND Submission

Phase 1/2

Product

Solid Tumours

LEU-001

Head and Neck (SCCHN)

T4

Phase 1/2

LEU-002

Multiple indications

NKG2DL

IND Submission

LEU-003

Multiple indications

ErbB

IND Submission

LEU-005

Multiple indications

NKG2DL (allogeneic)

Preclinical Development

LEU-007

Multiple indications

MUC1

Preclinical Development

LEU-008

Multiple indications

Integrin avb6

Preclinical Development

Haematological
Malignancies

B-cell malignancies

Undisclosed

IND Submission

LEU-004

Multiple indications

NKG2DL (allogeneic)

Preclinical Development

LEU-006

3rd Floor, Bermondsey Wing
Guys Hospital
London

SE1 9RT

© Leucid Bio Ltd

Contact Us